$XALL Xalles Holdings Reviews Q2 Achievements and 2020

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
228
$XALL Xalles Holdings Reviews Q2 Achievements and 2020 Outlook

WASHINGTON, DC, Aug. 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ? Xalles Holdings Inc. (OTC: XALL), a fintech holding company providing technology and financial services solutions, is pleased to announce the highlights from the second quarter disclosures and outlook for the remainder of 2020. Xalles has achieved many milestones during the last quarter and has demonstrated its ability to execute against its overall roadmap.

Q2 Achievements

Xalles Holdings released its Quarterly Report and Financial Statements yesterday on August 19, 2020 for the quarter ending June 30, 2020. Despite the challenges posed by the pandemic and the limited mobility of team members to travel, the second quarter of 2020 was record-setting as Xalles recorded its second consecutive quarter of profitability.

The balance sheet recorded a significant increase in the cash balance at the end of Q2 (greater than $200,000) compared to Q1, which was driven by new loans and equity investments.

During the second quarter, Xalles completed the closing of the Intel365, Inc. acquisition on May 15, 2020, and the Argus Technology Partners, Inc. acquisition on May 31, 2020.

2020 Outlook

Xalles will continue to foster the realization of synergies between the recently acquired companies. Argus Technology Partners is committed to selling the Brick by MinervaWorks and their Managed Services offerings to its channel partners and direct prospects. Intel365 is completing the development of its new background check services which can also be distributed through the Argus sales network.

Xalles is preparing to have a cryptocurrency technology-based trading solution ready to launch before the end of the third quarter, leveraging ATN Trading’s technology platform and the one-year-old partnership Xalles has with ATN. The recent strength in cryptocurrency is extremely favorable for our outlook, given Xalles Capital’s plans to acquire cryptocurrency assets in 2020.

In the third quarter, Xalles will invite the first group of fintech company applicants to become part of the Fintech Growth Center Program. This program will provide a unique opportunity to a select group of applicants that allows them to grow their company while under Xalles’ guidance and mentoring which could prime them for continued development and potential future acquisitions.

During the third quarter, Xalles will aim to complete the closings for 2 acquisitions previously announced, namely Adaptive Metadata Solutions and 1Rivet Global. Closing these acquisitions could result in a large increase in revenues this year and in 2021, while being transformative to the company. Xalles is also in discussions with a large pipeline of acquisition candidates while it pursues continuing fundraising efforts to support those deals.

Xalles is anticipating that its Reg A public offering will be qualified by the SEC during the third quarter which will give Xalles some flexibility in its fundraising plans going into 2021. The Xalles Holdings strategy also includes a plan to Uplist to the OTCQB (Quotation Board) prior to the end of 2020.

Xalles estimates at least $4,000,000 in 2020 revenue, based on the acquisitions already completed.

About Xalles Holdings Inc. (OTC: XALL)

Xalles Holdings Inc. is a holding company that focuses on direct investments in disruptive fintech companies. The company actively seeks acquisition targets in which it can invest and accelerate growth, targeting companies with solid management teams and business models, large total attainable markets (TAM), and lucrative exit opportunities. The company places emphasis on leveraging blockchain technologies to provide industry-leading financial reconciliation and auditing solutions, which, over time, will allow for the capture of recurring revenue streams. For more information visit: http://Xalles.com

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov and in OTC Markets at www.otcmarkets.com

Investor Relations Contact:
Info@Xalles.com
www.Xalles.com
202.595.1299 Office

Corporate Communications:
NetworkWire (NW)
New York, New York
http://www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 135

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 177

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 14

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 12

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Software Development with Agentic AI Features

Updated Category News Views 167

Progress Software Unveils New AI Features in Telerik and Kendo UI Progress Software is leading the way in enhancing application development with its latest update to Telerik and Kendo UI. This innovative release introduces groundbreaking agentic capabilities designed to empower developers with advanced tools for building enterprise-grade applications efficiently. With...

Continue Reading
Hao Pan's Share Transactions Reveal Insights at Orion Corporation

Updated Category News Views 245

Insights into Recent Share Transactions at Orion Corporation Orion Corporation actively engages in managing its share transactions, reflecting transparency and accountability within its operations. Recently, a significant disclosure involving Hao Pan, a senior manager at Orion Corporation, was shared under the guidelines of the Market Abuse Regulation. Who is Hao Pan? Hao...

Continue Reading
Analyzing Toast's Market Performance and Investor Sentiment

Updated Category News Views 142

Understanding Toast's Market Movements Toast Inc (NYSE: TOST) has recently seen a noticeable increase in the short percent of its float, which has risen to 9.06% compared to previous reports. This increase reflects a significant amount of activity, with approximately 32.58 million shares sold short. This statistic translates to 6.62% of all shares actively available for...

Continue Reading
Anthony Scaramucci Shares Insights on Memecoins and Digital Assets

Updated Category News Views 206

Scaramucci's View on Memecoins Renowned financial expert, Anthony Scaramucci, founder of SkyBridge Capital and an advocate for cryptocurrency, has made headlines with his bold predictions regarding the future of memecoins. He believes that the trajectory of these digital assets is likely set towards a decline. Limited Utility of Memecoins Identifying the Risks During a...

Continue Reading
Strengthening China-Africa Partnerships for a Shared Future

Updated Category News Views 121

Strengthening China-Africa Partnerships for Progress Recently, Chinese President Xi Jinping hosted a banquet attended by dignitaries from Africa and around the world, celebrating the strong ties between China and Africa. This event highlighted a shared commitment to building a community with a common future, showcasing how these two regions are collaborating for mutual...

Continue Reading